The analyses and visuals on this site are for informational purposes only and do not constitute investment advice.

© 2026 Datafin Financial Data Analysis Systems. All rights reserved. · v2.0

Privacy PolicyTerms of UseCookie Policy

ATNM FINANCIAL STATEMENTS

Actinium Pharmaceuticals Inc — balance sheet, income statement and cash flow trends

ATNMActinium Pharmaceuticals Inc

🇺🇸 USA · AMEX · Healthcare · Biotechnology

Value itDuel
PriceFinancialsPeers

Income Statement

Quarterly progression — trailing-twelve-month values
RevenueNet Income to Owners
-50 M-25 M025 M202120222023202420252026

Profit Funnel

Q2 2026 · TTM
Revenue35.1 M $Gross Profit35.5 M $ · 101%Operating Income9.6 M $ · 27%Pre-tax Income11.3 M $ · 32%Net Income to Owners11.3 M $ · 32%

Percentages are relative to revenue.

Key Figures

YoY change
Revenue35.1 M $+4,232.1%
Gross Profit35.5 M $—
Operating Income9.6 M $—
EBITDA12.2 M $—
Net Income to Owners11.3 M $—

No peer data is available for this stock.

Balance Sheet

Quarterly period-end values
Total AssetsTotal LiabilitiesEquity
050 M100 M202120222023202420252026

Capital Structure

Q2 2026
Total Assets40.2 M
  • Equity30.3 M $75%
  • Current Liabilities9.3 M $23%
  • Long-term Liabilities595 K $1%

Key Figures

YoY change
Total Assets40.2 M $-36.3%
Total Liabilities9.9 M $-77.6%
Total Equity30.3 M $+59.4%
Cash & ST Investments36.5 M $-39.1%
Total Debt1.3 M $+4.0%
Net Debt-35.1 M $—

No peer data is available for this stock.

Cash Flow Statement

Quarterly progression — trailing-twelve-month values
Operating Cash FlowCapital ExpendituresFree Cash Flow
-40 M-20 M0202120222023202420252026

Cash Flow Bridge

Q2 2026 · TTM
-20 M-10 M0-22.7 M $Operating-584 K $Investing-217 K $Financing-23.5 M $Net Change

Key Figures

YoY change
Operating Cash Flow-22.7 M $—
Capital Expenditures584 K $—
Free Cash Flow-23.2 M $—
Dividends Paid——

No peer data is available for this stock.

Amounts are in the company’s reporting currency. Peer comparison tables use ratio-based metrics so currency differences do not distort the picture.

Go deeper on ATNM

Run a DCF valuation

Full DCF model with editable assumptions

Start a head-to-head duel

Compare two stocks metric by metric

Filter in the stock screener

Build your own universe with 400+ metrics

Data on this page refreshes once per day. Price data as of Sep 11, 26. This content is for informational purposes only and is not investment advice.